Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of …
JP Gisbert, S Khorrami, F Carballo… - Cochrane Database …, 2004 - cochranelibrary.com
Background Peptic ulcer is the main cause for upper gastrointestinal haemorrhage, and
Helicobacter pylori (H. pylori) infection is the main etiologic factor for peptic ulcer disease …
Helicobacter pylori (H. pylori) infection is the main etiologic factor for peptic ulcer disease …
Intravenous Antibiotics in the Management of H. pylori Infection: A Systematic Review
YLA Chau, T Milic, J Perrott - Journal of Intensive Care …, 2024 - journals.sagepub.com
Background: Helicobacter pylori is implicated in the development of gastritis, ulcers, and
various gastric cancers, representing significant morbidity, mortality, and healthcare …
various gastric cancers, representing significant morbidity, mortality, and healthcare …
Intravenous metronidazole‐, levofloxacin‐containing triple therapy for treating patients with Helicobacter pylori‐related active peptic ulcer complications: A pilot study
W Zhang, Q Gui, J Chen, D Yu, W Su, C Zhu… - …, 2023 - Wiley Online Library
Objective The aim of this pilot study was to evaluate the efficacy and safety of intravenous
use esomeprazole, metronidazole, and/or levofloxacin in the treatment of Helicobacter pylori …
use esomeprazole, metronidazole, and/or levofloxacin in the treatment of Helicobacter pylori …
Three‐day intravenous triple therapy is not effective for the eradication of Helicobacter pyloriinfection in patients with bleeding gastro‐duodenal ulcer
M Romero‐Gómez, C Martínez‐Delgado… - Alimentary …, 2003 - Wiley Online Library
Aim: To test the efficacy of an ultra‐short intravenous triple therapy against Helicobacter
pylori infection in patients with bleeding peptic ulcer against standard oral 1‐week triple …
pylori infection in patients with bleeding peptic ulcer against standard oral 1‐week triple …
[PDF][PDF] The efficacy of triple and quadruple therapy for thetreatment of peptic ulcer disease
AE AI-Snafi, HKH Rijab - Tikrit journal of pharmaceutical sciences, 2005 - iasj.net
Abstract _ This study was designed to determine the efficacy oftriple and quadruple therapy
for_. the treatment of peptic urcer disease. Seventy five patients underw# Helicobacter Pylori …
for_. the treatment of peptic urcer disease. Seventy five patients underw# Helicobacter Pylori …
Three-day intravenous triple therapy is not effective for the eradication of infection in patients with bleeding gastro-duodenal ulcer.
M Romero‐Gómez… - Alimentary …, 2003 - search.ebscohost.com
To test the efficacy of an ultra-short intravenous triple therapy against Helicobacter pylori
infection in patients with bleeding peptic ulcer against standard oral 1-week triple therapy in …
infection in patients with bleeding peptic ulcer against standard oral 1-week triple therapy in …